AVITA Medical logo

AVITA MedicalNASDAQ: RCEL

Profile

Sector:

Healthcare

Country:

United States

IPO:

14 May 2012

Next earnings report:

07 November 2024

Last dividends:

N/A

Next dividends:

N/A
$267.69 M
-49%vs. 3y high
57%vs. sector
-vs. 3y high
-vs. sector
-21%vs. 3y high
93%vs. sector
-68%vs. 3y high
60%vs. sector

Price

after hours | Fri, 01 Nov 2024 20:02:15 GMT
$10.30+$0.40(+4.04%)

Dividend

No data over the past 3 years
$15.20 M$19.42 M
$15.20 M-$15.39 M

Analysts recommendations

Institutional Ownership

RCEL Latest News

AVITA Medical to Announce Third Quarter 2024 Financial Results
globenewswire.com10 October 2024 Sentiment: NEUTRAL

AVITA Medical announced that it will report its third quarter 2024 financial results after the close of the U.S. financial markets on November 7, 2024.

AVITA Medical Headed For Its Most Important Report, I'm Extremely Bullish
seekingalpha.com02 October 2024 Sentiment: POSITIVE

AVITA Medical's RECELL GO offers superior wound healing with less donor skin required, reducing scarring and infection risk. It has no direct competition. RECELL GO streamlines the skin grafting process, saving time and money. New products like PermeaDerm and Cohealyx offer additional growth opportunities. Despite the Q1 sales hiccup & high operating losses, AVITA's underlying technology still has promise. The stock should rally if the Q3 sales target is met & operating margins improve.

AVITA Medical: New Products, Same Old Cash Burn (Rating Downgrade)
seekingalpha.com27 August 2024 Sentiment: NEUTRAL

RECELL GO's launch increased SG&A expenses, contributing to AVITA Medical, Inc.'s higher net losses in Q2 2024. Despite lowering its 2024 revenue guidance, AVITA Medical still anticipates significant year-over-year growth of 37-41%. AVITA Medical's cash runway is approximately nine months, with $54.1 million in cash and securities available as of June 30, 2024.

AVITA Medical, Inc. (RCEL) Q2 2024 Earnings Call Transcript
seekingalpha.com09 August 2024 Sentiment: NEUTRAL

AVITA Medical, Inc. (NASDAQ:RCEL ) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Jessica Ekeberg - Director, Investor Relations Jim Corbett - Chief Executive Officer David O'Toole - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Joshua Jennings - TD Cowen Aaron Wukmir - Lake Street Capital Market Ross Osborne - Cantor Fitzgerald Lyanne Harrison - Bank of America Operator Good day and thank you for standing by. Welcome to the AVITA Medical Second Quarter Conference Call.

AVITA Medical to Host Investor Webinar Briefing
globenewswire.com08 August 2024 Sentiment: POSITIVE

VALENCIA, Calif., Aug. 08, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, invites shareholders and prospective investors to attend its investor webinar briefing and presentation by Jim Corbett, Chief Executive Officer, and David O'Toole, Chief Financial Officer, on August 13, 2024, at 4:00 p.m.

AVITA Medical Reports Second Quarter Financial Results
globenewswire.com08 August 2024 Sentiment: POSITIVE

AVITA Medical today reported second-quarter commercial revenue of $15.1 million, reflecting growth of over 29% over the same period in the prior year.

AVITA Medical to Announce Second Quarter 2024 Financial Results
globenewswire.com11 July 2024 Sentiment: POSITIVE

VALENCIA, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that it will report its second quarter 2024 financial results after the close of the U.S. financial markets on Thursday, August 8, 2024.

AVITA Medical Appoints Nicole Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary
globenewswire.com01 July 2024 Sentiment: POSITIVE

VALENCIA, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced the appointment of Nicole Linda Kelsey as Chief Legal and Compliance Officer, and Corporate Secretary, effective July 1, 2024.

AVITA Medical Achieves Milestone with First Case Using RECELL GO
globenewswire.com05 June 2024 Sentiment: POSITIVE

VALENCIA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the Joseph M.

AVITA Medical Announces FDA Approval of RECELL GO
globenewswire.com30 May 2024 Sentiment: POSITIVE

VALENCIA, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin restoration, today announced that the U.S. Food and Drug Administration (FDA) has approved its premarket approval (PMA) supplement for the RECELL GO™ System, its next-generation autologous cell harvesting device that harnesses the regenerative properties of a patient's own skin to treat thermal burn wounds and full-thickness skin defects.

  • 1(current)

What type of business is AVITA Medical?

AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California.

What sector is AVITA Medical in?

AVITA Medical is in the Healthcare sector

What industry is AVITA Medical in?

AVITA Medical is in the Medical Devices industry

What country is AVITA Medical from?

AVITA Medical is headquartered in United States

When did AVITA Medical go public?

AVITA Medical initial public offering (IPO) was on 14 May 2012

What is AVITA Medical website?

https://www.avitamedical.com

Is AVITA Medical in the S&P 500?

No, AVITA Medical is not included in the S&P 500 index

Is AVITA Medical in the NASDAQ 100?

No, AVITA Medical is not included in the NASDAQ 100 index

Is AVITA Medical in the Dow Jones?

No, AVITA Medical is not included in the Dow Jones index

When was AVITA Medical the previous earnings report?

No data

When does AVITA Medical earnings report?

The next expected earnings date for AVITA Medical is 07 November 2024